IPIC Message Board - Msg: 2993351

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Graham Marshman who wrote (941)	12/17/1997 9:16:00 PM
From: NeuroInvestment	Read Replies (2) of 1359

The NDA submission had already been factored into the current price....it was no surprise, IPIC had said it would be submitted before year-end, and it was. It will be the FDA response that will be a factor in price movement, particularly in terms of scheduling an Advisory Committee hearing. I do not believe that the FDA will in any way 'punish' IPIC, I fully expect expedited approval. Those who believe that IPIC withheld information from the FDA will suggest otherwise, but my information is that IPIC sent everything to the FDA that should have been sent, and that the FDA knows this. There is nothing to punish IPIC for. The Redux issue continues to hang over everything Interneuron does, and until there is some clarification of the valvular damage/liability issues (which may take into April to occur), there will be a dampening effect on all upside moves. It is not that the market "presumes" damage from Redux, but the market truly does "fear" it, and it will take a considerable body of high quality data to assuage those fears. NeuroInvestment

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next